Knights of Columbus Asset Advisors LLC Cuts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Knights of Columbus Asset Advisors LLC lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,292 shares of the medical equipment provider’s stock after selling 463 shares during the quarter. Knights of Columbus Asset Advisors LLC’s holdings in Intuitive Surgical were worth $6,416,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of ISRG. Bennett Selby Investments LP lifted its position in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after acquiring an additional 17 shares during the period. Onefund LLC lifted its position in shares of Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after acquiring an additional 18 shares during the period. LVW Advisors LLC increased its stake in shares of Intuitive Surgical by 1.3% during the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. increased its stake in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC increased its stake in shares of Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after purchasing an additional 19 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now owns 3,282 shares in the company, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. The trade was a 53.61 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Up 0.1 %

Shares of ISRG opened at $492.49 on Friday. The firm has a market cap of $175.41 billion, a PE ratio of 76.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The company’s fifty day moving average is $562.24 and its two-hundred day moving average is $531.34. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on ISRG shares. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Citigroup raised their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Evercore ISI raised their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective for the company. Finally, Bernstein Bank lifted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.